Archive: March 2018
HCC
Update on New Drugs and Those in Development for the Treatment of Primary Biliary Cholangitis
Runalia Bahar, MD, Kimberly A. Wong, MD, Chung H. Liu, and Christopher L. Bowlus, MD
Abstract: Primary biliary cholangitis (PBC) is an autoimmune inflammatory liver disease of the interlobular bile ducts that can lead to cirrhosis and liver failure. Until […]
Proton Pump Inhibitors
The Role of Proton Pump Inhibitors in the Management of Upper Gastrointestinal Disorders
Muhammad Ali Khan, MD, and Colin W. Howden, MD
Abstract: Proton pump inhibitors (PPIs) have been in use since the early 1990s and play a crucial role in the management of a number of […]
IBD
Contraceptive Use in Women With Inflammatory Bowel Disease
Lori M. Gawron, MD, MPH
G&H How common is inflammatory bowel disease in women of childbearing age? LG Inflammatory bowel disease (IBD) impacts approximately 1.6 million Americans and is equally as […]
GERD
Management of Refractory Benign Esophageal Strictures
Peter D. Siersema, MD, PhD
G&H What are the most common causes of esophageal strictures? PS A variety of disorders can cause esophageal strictures, including both malignant and benign etiologies. […]
Gastroparesis
A Critical Review of the Current Clinical Landscape of Gastroparesis
Chimi L. Fosso, MD, and Eamonn M. M. Quigley, MD, FRCP, FRCPI
Abstract: Gastroparesis has emerged as a common gastrointestinal disorder over the past few decades. It has been questioned whether this increase in prevalence reflects a […]
Hepatitis C
Shortening Treatment for Hepatitis C Virus Infection
Shyam Kottilil, MD, PhD
G&H How has treatment duration changed from the first direct-acting antiviral agents to those currently being used in patients with hepatitis C virus infection? SK […]
Endoscopy
Endoscopic Management of Incidentally Identified Gastrointestinal Stromal Tumors
Michael B. Wallace, MD, MPH
G&H How common are gastrointestinal stromal tumors, and how often are they identified incidentally? MW Gastrointestinal stromal tumors (GISTs) are quite common and include a […]
Letter From the Editor
Letter From the Editor: Proton Pump Inhibitors
Gary R. Lichtenstein, MD, AGAF, FACP, FACG
For nearly 3 decades, proton pump inhibitors have played an important role in the management of the upper gastrointestinal tract. In this month’s issue of Gastroenterology […]